Literature DB >> 1655738

Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1.

B Peers1, P Monget, M A Nalda, M L Voz, M Berwaer, A Belayew, J A Martial.   

Abstract

To identify the cis-acting elements responsible for cAMP stimulation of human prolactin (hPRL) promoter activity, pituitary GC cells were transfected with 5'-deleted hPRL promoters fused to the chloramphenicol acetyltransferase reporter gene. The proximal regulatory region (coordinates -250 to -42) was sufficient to confer strong cAMP stimulation (+/- 25 fold). Further 5' and 3' deletions performed within this proximal region demonstrated that two types of cis-acting elements are involved in the cAMP regulation: (i) the binding sites of the pituitary-specific factor Pit-1, and (ii) the sequence between coordinates -115 and -85 (named fragment A), which contains a TGACG motif. We show by gel-shift and Southwestern experiments that fragment A binds Pit-1 monomer and also a ubiquitous factor that is neither cAMP-responsive element-binding protein nor activator protein-1. Strong cAMP induction was observed when fragment A was juxtaposed to a Pit-1 binding site. That Pit-1 plays an important role was supported further by the finding that the hPRL proximal region conferred cAMP regulation when linked to the herpes simplex virus thymidine kinase promoter only in pituitary GC cells and not in other heterologous cells, which do not express Pit-1. Furthermore, we observed that concatenated Pit-1 binding sites were able to confer cAMP responsiveness to the thymidine kinase promoter in GC cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Hormonal regulation of the thyrotropin beta-subunit gene by phosphorylation of the pituitary-specific transcription factor Pit-1.

Authors:  H J Steinfelder; S Radovick; F E Wondisford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 2.  Hormone response units: one plus one equals more than two.

Authors:  W J Roesler; E A Park
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

Review 3.  Genetic aspects of central hypothyroidism.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

4.  Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.

Authors:  R E Schweppe; A Gutierrez-Hartmann
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

5.  Transcriptional induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif.

Authors:  S Germain; T Konoshita; J Philippe; P Corvol; F Pinet
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

6.  Methionine sulfoxide reductase: a novel schizophrenia candidate gene.

Authors:  Consuelo Walss-Bass; Maria Clara Soto-Bernardini; Teresa Johnson-Pais; Robin J Leach; Alfonso Ontiveros; Humberto Nicolini; Ricardo Mendoza; Alvaro Jerez; Albana Dassori; Ivan Chavarria-Siles; Michael A Escamilla; Henriette Raventos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

7.  Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.

Authors:  K E Conrad; J M Oberwetter; R Vaillancourt; G L Johnson; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.

Authors:  I Ben-Batalla; S Seoane; M Macia; T Garcia-Caballero; L O Gonzalez; F Vizoso; R Perez-Fernandez
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.